Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Rinaldi, MG' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 156 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dykstra, MJ; Astrofsky, KM; Schrenzel, MD; Fox, JG; Bullis, RA; Farrington, S; Sigler, L; Rinaldi, MG; McGinnis, MR
      High mortality in a large-scale zebrafish colony (Brachydanio rerio Hamilton & Buchanan, 1822) associated with Lecythophora mutabilis (van Beyma) W. Gam's & McGinnis

      COMPARATIVE MEDICINE
    2. Redding, SW; Bailey, CW; Lopez-Ribot, JL; Kirkpatrick, WR; Fothergill, AW; Rinaldi, MG; Patterson, TF
      Candida dubliniensis in radiation-induced oropharyngeal candidiasis

      ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
    3. Blumberg, HM; Jarvis, WR; Soucie, JM; Edwards, JE; Patterson, JE; Pfaller, MA; Rangel-Frausto, MS; Rinaldi, MG; Saiman, L; Wiblin, RT; Wenzel, RP
      Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study

      CLINICAL INFECTIOUS DISEASES
    4. Rex, JH; Pfaller, MA; Walsh, TJ; Chaturvedi, V; Espinel-Ingroff, A; Ghannoum, MA; Gosey, LL; Odds, FC; Rinaldi, MG; Sheehan, DJ; Warnock, DW
      Antifungal susceptibility testing: Practical aspects and current challenges

      CLINICAL MICROBIOLOGY REVIEWS
    5. Jani, BR; Rinaldi, MG; Reinhart, WJ
      An unusual case of fungal keratitis - Metarrhizium anisopliae

      CORNEA
    6. Korzets, A; Weinberger, M; Chagnac, A; Goldschmied-Reouven, A; Rinaldi, MG; Sutton, DA
      Peritonitis due to Thermoascus taitungiacus (anamorph Paecilomyces taitungiacus)

      JOURNAL OF CLINICAL MICROBIOLOGY
    7. Perea, S; Fothergill, AW; Sutton, DA; Rinaldi, MG
      Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method

      JOURNAL OF CLINICAL MICROBIOLOGY
    8. Gonzalez, GM; Tijerina, R; Najvar, LK; Bocanegra, R; Luther, M; Rinaldi, MG; Graybill, JR
      Correlation between antifungal susceptibilities of Coccidioides immitis invitro and antifungal treatment with caspofungin in a mouse model

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    9. Gonzalez, GM; Sutton, DA; Thompson, E; Tijerina, R; Rinaldi, MG
      In vitro activities of approved and investigational antifungal agents against 44 clinical isolates of basidiomycetous fungi

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    10. Reidarson, TH; McBain, JF; Dalton, LM; Rinaldi, MG
      Mycotic diseases

      CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION
    11. Hagman, HM; Madnick, EG; D'Agostino, AN; Williams, PL; Shatsky, S; Mirels, LF; Tucker, RM; Rinaldi, MG; Stevens, DA; Bryant, RE
      Hyphal forms in the central nervous system of patients with coccidioidomycosis

      CLINICAL INFECTIOUS DISEASES
    12. Yildiran, ST; Saracli, MA; Fothergill, AW; Rinaldi, MG
      In vitro susceptibility of environmental Cryptococcus neoformans variety neoformans isolates from Turkey to six antifungal agents, including SCH56592and voriconazole

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    13. Burgess, DS; Hastings, RW; Summers, KK; Hardin, TC; Rinaldi, MG
      Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    14. Rinaldi, MG
      Dermatophytosis: Epidemiological and microbiological update

      JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
    15. Iwen, PC; Tarantolo, SR; Sutton, DA; Rinaldi, MG; Hinrichs, SH
      Cutaneous infection caused by Cylindrocarpon lichenicola in a patient withacute myelogenous leukemia

      JOURNAL OF CLINICAL MICROBIOLOGY
    16. Barry, AL; Pfaller, MA; Brown, SD; Espinel-Ingroff, A; Ghannoum, MA; Knapp, C; Rennie, RP; Rex, JH; Rinaldi, MG
      Quality control limits for broth microdilution susceptibility tests of tenantifungal agents

      JOURNAL OF CLINICAL MICROBIOLOGY
    17. Khan, ZU; Kortom, M; Marouf, R; Chandy, R; Rinaldi, MG; Sutton, DA
      Bilateral pulmonary aspergilloma caused by an atypical isolate of Aspergillus terreus

      JOURNAL OF CLINICAL MICROBIOLOGY
    18. Al-Mohsen, IZ; Sutton, DA; Sigler, L; Almodovar, E; Mahgoub, N; Frayha, H; Al-Hajjar, S; Rinaldi, MG; Walsh, TJ
      Acrophialophora fusispora brain abscess in a child with acute lymphoblastic leukemia: Review of cases and taxonomy

      JOURNAL OF CLINICAL MICROBIOLOGY
    19. Iwen, PC; Sigler, L; Tarantolo, S; Sutton, DA; Rinaldi, MG; Lackner, RP; McCarthy, DI; Hinrichs, SH
      Pulmonary infection caused by Gymnascella hyalinospora in a patient with acute myelogenous leukemia

      JOURNAL OF CLINICAL MICROBIOLOGY
    20. Al-Abdely, HM; Najvar, L; Bocanegra, R; Fothergill, A; Loebenberg, D; Rinaldi, MG; Graybill, JR
      SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum ("Ramichloridium mackenziei")

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    21. Perea, S; Pennick, GJ; Modak, A; Fothergill, AW; Sutton, DA; Sheehan, DJ; Rinaldi, MG
      Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    22. Kirkpatrick, WR; McAtee, RK; Fothergill, AW; Loebenberg, D; Rinaldi, MG; Patterson, TF
      Efficacy of SCH56592 in a rabbit model of invasive aspergillosis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    23. Kirkpatrick, WR; McAtee, RK; Fothergill, AW; Rinaldi, MG; Patterson, TF
      Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    24. Barchiesi, F; Arzeni, D; Fothergill, AW; Di Francesco, LF; Caselli, F; Rinaldi, MG; Scalise, G
      In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    25. Patterson, TF; Kirkpatrick, WR; White, M; Hiemenz, JW; Wingard, JR; Dupont, B; Rinaldi, MG; Stevens, DA; Graybill, JR
      Invasive aspergillosis - Disease spectrum, treatment practices, and outcomes

      MEDICINE
    26. Galgiani, JN; Catanzaro, A; Cloud, GA; Johnson, RH; Williams, PL; Mirels, LF; Nassar, F; Lutz, JE; Stevens, DA; Sharkey, PK; Singh, VR; Larsen, RA; Delgado, KL; Flanigan, C; Rinaldi, MG
      Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis - A randomized, double-blind trial

      ANNALS OF INTERNAL MEDICINE
    27. Lin, AL; Shi, QH; Johnson, DA; Paterson, TF; Rinaldi, MG; Yeh, CK
      Further characterization of human salivary anticandidal activities in a human immunodeficiency virus-positive cohort by use of microassays

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    28. Barchiesi, F; Schimizzi, AM; Fothergill, AW; Scalise, G; Rinaldi, MG
      In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    29. Odds, FC; Dupont, B; Rinaldi, MG; Stevens, DA; Warnock, DW; Woestenborghs, R
      Bioassays for itraconazole blood levels: an interlaboratory collaborative study

      Journal of antimicrobial chemotherapy
    30. Marco, F; Lockhart, SR; Pfaller, MA; Pujol, C; Rangel-Frausto, MS; Wiblin, T; Blumberg, HM; Edwards, JE; Jarvis, W; Saiman, L; Patterson, JE; Rinaldi, MG; Wenzel, RP; Soll, DR
      Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3

      JOURNAL OF CLINICAL MICROBIOLOGY
    31. Sutton, DA; Sanche, SE; Revankar, SG; Fothergill, AW; Rinaldi, MG
      In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole

      JOURNAL OF CLINICAL MICROBIOLOGY
    32. Laurel, VL; Meier, PA; Astorga, A; Dolan, D; Brockett, R; Rinaldi, MG
      Pseudoepidemic of Aspergillus niger infections traced to specimen contamination in the microbiology laboratory

      JOURNAL OF CLINICAL MICROBIOLOGY
    33. Richter, S; Cormican, MG; Pfaller, MA; Lee, CK; Gingrich, R; Rinaldi, MG; Sutton, DA
      Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient: Species identification and review of the literature

      JOURNAL OF CLINICAL MICROBIOLOGY
    34. Sutton, DA; Timm, WD; Morgan-Jones, G; Rinaldi, MG
      Human phaeohyphomycotic osteomyelitis caused by the coelomycete Phomopsis saccardo 1905: Criteria for identification, case history, and therapy

      JOURNAL OF CLINICAL MICROBIOLOGY
    35. Redding, SW; Zellars, RC; Kirkpatrick, WR; McAtee, RK; Caceres, MA; Fothergill, AW; Lopez-Ribot, JL; Bailey, CW; Rinaldi, MG; Patterson, TF
      Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer

      JOURNAL OF CLINICAL MICROBIOLOGY
    36. Revankar, SG; Sutton, DA; Sanche, SE; Rao, JT; Zervos, M; Dashti, F; Rinaldi, MG
      Metarrhizium anisopliae as a cause of sinusitis in immunocompetent hosts

      JOURNAL OF CLINICAL MICROBIOLOGY
    37. Lopez-Ribot, JL; McAtee, RK; Perea, S; Kirkpatrick, WR; Rinaldi, MG; Patterson, TF
      Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    38. Li, RK; Rinaldi, MG
      In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    39. MCGINNIS MR; PASARELL L; SUTTON DA; FOTHERGILL AW; COOPER CR; RINALDI MG
      IN-VITRO ACTIVITY OF VORICONAZOLE AGAINST SELECTED FUNGI

      MEDICAL MYCOLOGY
    40. COLEMAN DC; RINALDI MG; HAYNES KA; REX JH; SUMMERBELL RC; ANAISSIE EJ; LI A; SULLIVAN DJ
      IMPORTANCE OF CANDIDA SPECIES OTHER THAN CANDIDA-ALBICANS AS OPPORTUNISTIC PATHOGENS

      MEDICAL MYCOLOGY
    41. MASCARENAS CA; HARDIN TC; PENNICK GJ; RINALDI MG; GRAYBILL JR
      TREATMENT OF THRUSH WITH ITRACONAZOLE SOLUTION - EVIDENCE FOR TOPICALEFFECT

      Clinical infectious diseases
    42. REVANKAR SG; DIB OP; KIRKPATRICK WR; MCATEE RK; FOTHERGILL AW; RINALDI MG; REDDING SW; PATTERSON TF
      CLINICAL-EVALUATION AND MICROBIOLOGY OF OROPHARYNGEAL INFECTION DUE TO FLUCONAZOLE-RESISTANT CANDIDA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS

      Clinical infectious diseases
    43. FURUKAWA H; KUSNE S; SUTTON DA; MANEZ R; CARRAU R; NICHOLS L; ABUELMAGD K; SKEDROS D; TODO S; RINALDI MG
      ACUTE INVASIVE SINUSITIS DUE TO TRICHODERMA-LONGIBRACHIATUM IN A LIVER AND SMALL-BOWEL TRANSPLANT RECIPIENT

      Clinical infectious diseases
    44. Shenep, JL; English, BK; Kaufman, L; Pearson, TA; Thompson, JW; Kaufman, RA; Frisch, G; Rinaldi, MG
      Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child

      CLINICAL INFECTIOUS DISEASES
    45. Reidarson, TH; Harrell, JH; Rinaldi, MG; McBain, J
      Bronchoscopic and serologic diagnosis of Aspergillus fumigatus pulmonary infection in a bottlenose dolphin (Tursiops truncatus)

      JOURNAL OF ZOO AND WILDLIFE MEDICINE
    46. PRZYKUCKI JM; SADKOWSKI L; THOMPSON C; RINALDI MG; PATTERSON JE
      COMPARISON OF FLOOR BUFFERS AS A SOURCE OF AEROSOLIZATION OF FUNGAL SPORES IN A BONE-MARROW TRANSPLANT UNIT (BMTU)

      Infection control and hospital epidemiology
    47. PFALLER MA; MESSER SA; HOUSTON A; RANGELFRAUSTO MS; WIBLIN T; BLUMBERG HM; EDWARDS JE; JARVIS W; MARTIN MA; NEU HC; SAIMAN L; PATTERSON JE; DIBB JC; ROLDAN CM; RINALDI MG; WENZEL RP
      NATIONAL EPIDEMIOLOGY OF MYCOSES SURVEY - A MULTICENTER STUDY OF STRAIN VARIATION AND ANTIFUNGAL SUSCEPTIBILITY AMONG ISOLATES OF CANDIDA SPECIES

      Diagnostic microbiology and infectious disease
    48. SHIN JH; LEE SK; SUH SP; RYANG SW; KIM NH; RINALDI MG; SUTTON DA
      FATAL HORMONEMA-DEMATIOIDES PERITONITIS IN A PATIENT ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS - CRITERIA FOR ORGANISM IDENTIFICATION AND REVIEW OF OTHER KNOWN FUNGAL ETIOLOGIC AGENTS

      Journal of clinical microbiology
    49. KIRKPATRICK WR; MCATEE RK; REVANKAR SG; FOTHERGILL AW; MCCARTHY DI; RINALDI MG; PATTERSON TF
      COMPARATIVE-EVALUATION OF NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS BROTH MACRODILUTION AND AGAR DILUTION SCREENING METHODS FOR TESTING FLUCONAZOLE SUSCEPTIBILITY OF CRYPTOCOCCUS-NEOFORMANS

      Journal of clinical microbiology
    50. SUTTON DA; SLIFKIN M; YAKULIS R; RINALDI MG
      US CASE-REPORT OF CEREBRAL PHEOHYPHOMYCOSIS CAUSED BY RAMICHLORIDIUM-OBOVOIDEUM (R-MACKENZIEI) - CRITERIA FOR IDENTIFICATION, THERAPY, AND REVIEW OF OTHER KNOWN DEMATIACEOUS NEUROTROPIC TAXA

      Journal of clinical microbiology
    51. IWEN PC; RUPP ME; BISHOP MR; RINALDI MG; SUTTON DA; TARANTOLO S; HINRICHS SH
      DISSEMINATED ASPERGILLOSIS CAUSED BY ASPERGILLUS-USTUS IN A PATIENT FOLLOWING ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION

      Journal of clinical microbiology (Print)
    52. KIRKPATRICK WR; TURNER TM; FOTHERGILL AW; MCCARTHY DI; REDDING SW; RINALDI MG; PATTERSON TF
      FLUCONAZOLE DISK DIFFUSION SUSCEPTIBILITY TESTING OF CANDIDA SPECIES

      Journal of clinical microbiology (Print)
    53. KIRKPATRICK WR; REVANKAR SG; MCATEE RK; LOPEZRIBOT JL; FOTHERGILL AW; MCCARTHY DI; SANCHE SE; CANTU RA; RINALDI MG; PATTERSON TF
      DETECTION OF CANDIDA-DUBLINIENSIS IN OROPHARYNGEAL SAMPLES FROM HUMANIMMUNODEFICIENCY VIRUS-INFECTED PATIENTS IN NORTH-AMERICA BY PRIMARY CHROMAGAR CANDIDA SCREENING AND SUSCEPTIBILITY TESTING OF ISOLATES

      Journal of clinical microbiology
    54. REVANKAR SG; KIRKPATRICK WR; MCATEE RK; FOTHERGILL AW; REDDING SW; RINALDI MG; PATTERSON TF
      INTERPRETATION OF TRAILING END-POINTS IN ANTIFUNGAL SUSCEPTIBILITY TESTING BY THE NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS METHOD

      Journal of clinical microbiology
    55. CHAPMAN SW; ROGERS PD; RINALDI MG; SULLIVAN DC
      SUSCEPTIBILITIES OF CLINICAL AND LABORATORY ISOLATES OF BLASTOMYCES-DERMATITIDIS TO KETOCONAZOLE, ITRACONAZOLE, AND FLUCONAZOLE

      Antimicrobial agents and chemotherapy
    56. ODDS FC; VANGERVEN F; ESPINELINGROFF A; BARTLETT MS; GHANNOUM MA; LANCASTER MV; PFALLER MA; REX JH; RINALDI MG; WALSH TJ
      EVALUATION OF POSSIBLE CORRELATIONS BETWEEN ANTIFUNGAL SUSCEPTIBILITIES OF FILAMENTOUS FUNGI IN-VITRO AND ANTIFUNGAL TREATMENT OUTCOMES IN ANIMAL INFECTION MODELS

      Antimicrobial agents and chemotherapy
    57. GRAYBILL JR; NAJVAR LK; MONTALBO EM; BARCHIESI FJ; LUTHER MF; RINALDI MG
      TREATMENT OF HISTOPLASMOSIS WITH MK-991 (L-743,872)

      Antimicrobial agents and chemotherapy
    58. NGUYEN MH; CLANCY CJ; YU VL; YU YC; MORRIS AJ; SNYDMAN DR; SUTTON DA; RINALDI MG
      DO IN-VITRO SUSCEPTIBILITY DATA PREDICT THE MICROBIOLOGIC RESPONSE TOAMPHOTERICIN-B - RESULTS OF A PROSPECTIVE-STUDY OF PATIENTS WITH CANDIDA-FUNGEMIA

      The Journal of infectious diseases
    59. LIN AL; SHI Q; SHENTU S; JOHNSON DA; RINALDI MG; YEH CK
      FURTHER CHARACTERIZATION OF SALIVARY ANTICANDIDAL ASSAYS

      Journal of dental research
    60. REVANKAR SG; KIRKPATRICK WR; MCATEE RK; FOTHERGILL AW; REDDING SW; RINALDI MG; HILSENBECK SG; PATTERSON TF
      A RANDOMIZED TRIAL OF CONTINUOUS OR INTERMITTENT THERAPY WITH FLUCONAZOLE FOR OROPHARYNGEAL CANDIDIASIS IN HIV-INFECTED PATIENTS - CLINICALOUTCOMES AND DEVELOPMENT OF FLUCONAZOLE RESISTANCE

      The American journal of medicine
    61. CLEARY JD; CHAPMAN SW; HARDIN TC; RINALDI MG; SPENCER JL; DENG J; PENNICK GJ; LOBB CJ
      AMPHOTERICIN-B ENZYME-LINKED IMMUNOASSAY FOR CLINICAL USE - COMPARISON WITH BIOASSAY AND HPLC

      The Annals of pharmacotherapy
    62. MCGINNIS MR; RINALDI MG
      SOME MEDICALLY IMPORTANT FUNGI AND THEIR COMMON SYNONYMS AND OBSOLETENAMES

      Clinical infectious diseases
    63. PFALLER MA; REX JH; RINALDI MG
      ANTIFUNGAL SUSCEPTIBILITY TESTING - TECHNICAL ADVANCES AND POTENTIAL CLINICAL-APPLICATIONS

      Clinical infectious diseases
    64. REX JH; PFALLER MA; GALGIANI JN; BARTLETT MS; ESPINELINGROFF A; GHANNOUM MA; LANCASTER M; ODDS FC; RINALDI MG; WALSH TJ; BARRY AL
      DEVELOPMENT OF INTERPRETIVE BREAKPOINTS FOR ANTIFUNGAL SUSCEPTIBILITYTESTING - CONCEPTUAL-FRAMEWORK AND ANALYSIS OF IN-VITRO IN-VIVO CORRELATION DATA FOR FLUCONAZOLE, ITRACONAZOLE, AND CANDIDA INFECTIONS

      Clinical infectious diseases
    65. RINALDI MG
      CONTROVERSIES IN MEDICAL MYCOLOGY

      Dermatology
    66. DUBE MP; HESELTINE PNR; RINALDI MG
      LETTER TO THE EDITOR - NYSTATIN PROPHYLAXIS

      Clinical microbiology reviews
    67. DUBE MP; HESELTINE PNR; RINALDI MG
      LETTER TO THE EDITOR - NYSTATIN PROPHYLAXIS

      Clinical microbiology reviews
    68. RINALDI MG
      THE CHANGING MYCOLOGY OF CANDIDIASIS - NEW AND RESISTANT PATHOGENS

      AIDS patient care
    69. YEE RW; CHENG CJ; MEENAKSHI S; LUDDEN TM; WALLACE JE; RINALDI MG
      OCULAR PENETRATION AND PHARMACOKINETICS OF TOPICAL FLUCONAZOLE

      Cornea
    70. HARDIN TC; NAJVAR LK; RIZZO J; FOTHERGILL AW; RINALDI MG; GRAYBILL JR
      DISCREPANCY BETWEEN IN-VITRO AND IN-VIVO ANTIFUNGAL ACTIVITY OF ALBENDAZOLE

      Journal of medical and veterinary mycology
    71. REDDING SW; PFALLER MA; MESSER SA; SMITH JA; PROWS J; BRADLEY LL; FOTHERGILL AW; RINALDI MG
      VARIATIONS IN FLUCONAZOLE SUSCEPTIBILITY AND DNA SUBTYPING OF MULTIPLE CANDIDA-ALBICANS COLONIES FROM PATIENTS WITH AIDS AND ORAL CANDIDIASIS SUFFERING ONE OR MORE EPISODES OF INFECTION

      Journal of clinical microbiology
    72. SUTTON DA; PADHYE AA; STANDARD PG; RINALDI MG
      AN ABERRANT VARIANT OF HISTOPLASMA-CAPSULATUM VAR CAPSULATUM

      Journal of clinical microbiology
    73. SIGLER L; SUMMERBELL RC; POOLE L; WIEDEN M; SUTTON DA; RINALDI MG; AGUIRRE M; ESTES GW; GALGIANI JN
      INVASIVE NATTRASSIN-MANGIFERAE INFECTIONS - CASE-REPORT, LITERATURE-REVIEW, AND THERAPEUTIC AND TAXONOMIC APPRAISAL

      Journal of clinical microbiology
    74. MUNOZ FM; DEMMLER GJ; TRAVIS WR; OGDEN AK; ROSSMANN SN; RINALDI MG
      TRICHODERMA-LONGIBRACHIATUM INFECTION IN A PEDIATRIC-PATIENT WITH APLASTIC-ANEMIA

      Journal of clinical microbiology
    75. ESPINELINGROFF A; BARTLETT M; BOWDEN R; CHIN NX; COOPER C; FOTHERGILL A; MCGINNIS MR; MENEZES P; MESSER SA; NELSON PW; ODDS FC; PASARELL L; PETER J; PFALLER MA; REX JH; RINALDI MG; SHANKLAND GS; WALSH TJ; WEITZMAN I
      MULTICENTER EVALUATION OF PROPOSED STANDARDIZED PROCEDURE FOR ANTIFUNGAL SUSCEPTIBILITY TESTING OF FILAMENTOUS FUNGI

      Journal of clinical microbiology
    76. ODDS FC; RINALDI MG; COOPER CR; FOTHERGILL A; PASARELL L; MCGINNIS MR
      CANDIDA AND TORULOPSIS - A BLINDED EVALUATION OF USE OF PSEUDOHYPHA FORMATION AS BASIS FOR IDENTIFICATION OF MEDICALLY IMPORTANT YEASTS

      Journal of clinical microbiology
    77. MCGINNIS MR; PASARELL L; SUTTON DA; FOTHERGILL AW; COOPER CR; RINALDI MG
      IN-VITRO EVALUATION OF VORICONAZOLE AGAINST SOME CLINICALLY IMPORTANTFUNGI

      Antimicrobial agents and chemotherapy
    78. VENKATESWARLU K; TAYLOR M; MANNING NJ; RINALDI MG; KELLY SL
      FLUCONAZOLE TOLERANCE IN CLINICAL ISOLATES OF CRYPTOCOCCUS-NEOFORMANS

      Antimicrobial agents and chemotherapy
    79. DIB OP; REVANKAR SG; KIRKPATRICK WR; MCATEE RK; FOTHERGILL AW; RINALDI MG; REDDING SW; PATTERSON TF
      CORRELATION OF SIGNS, SYMPTOMS AND MICROBIOLOGY WITH THERAPEUTIC RESPONSE IN OROPHARYNGEAL CANDIDIASIS IN HIV-INFECTED PATIENTS

      Journal of dental research
    80. SINGH N; BARNISH MJ; BERMAN S; BENDER BS; WAGENER MM; RINALDI MG; YU VL
      LOW-DOSE FLUCONAZOLE AS PRIMARY PROPHYLAXIS FOR CRYPTOCOCCAL INFECTION IN AIDS PATIENTS WITH CD4 CELL COUNTS OF LESS-THAN-OR-EQUAL-TO-100 MM(3) - DEMONSTRATION OF EFFICACY IN A PROSPECTIVE, MULTICENTER TRIAL/

      Clinical infectious diseases
    81. REVANKAR SG; KIRKPATRICK WR; MCATEE RK; DIB O; FOTHERGILL AE; REDDING SW; RINALDI MG; PATTERSON TF
      DEVELOPMENT OF FLUCONAZOLE RESISTANCE WITH CONTINUOUS VS INTERMITTENTTHERAPY IN OROPHARYNGEAL CANDIDIASIS IN HIV-INFECTED PATIENTS

      Clinical infectious diseases
    82. NGUYEN MH; MORRIS AJ; DOBSON ME; SNYDMAN DR; PEACOCK JE; RINALDI MG; YU VL
      CANDIDA LUSITANIAE - AN IMPORTANT EMERGING CAUSE OF CANDIDEMIA

      Infectious diseases in clinical practice
    83. RINALDI MG
      EPIDEMIOLOGY OF MYCOSES IN THE HIV-INFECTED PATIENT - CLINICAL ASPECTS

      International journal of antimicrobial agents
    84. LEGENDRE AM; ROHRBACH BW; TOAL RL; RINALDI MG; GRACE LL; JONES JB
      TREATMENT OF BLASTOMYCOSIS WITH ITRACONAZOLE IN 112 DOGS

      Journal of veterinary internal medicine
    85. RINALDI MG
      PHEOHYPHOMYCOSIS

      Dermatologic clinics
    86. REDKAR RJ; DUBE MP; MCCLESKEY FK; RINALDI MG; DELVECCHIO VG
      DNA-FINGERPRINTING OF CANDIDA-RUGOSA VIA REPETITIVE SEQUENCE-BASED PCR

      Journal of clinical microbiology
    87. PATTERSON TF; REVANKAR SG; KIRKPATRICK WR; DIB O; FOTHERGILL AW; REDDING SW; SUTTON DA; RINALDI MG
      SIMPLE METHOD FOR DETECTING FLUCONAZOLE-RESISTANT YEASTS WITH CHROMOGENIC AGAR

      Journal of clinical microbiology
    88. DIB JC; DUBE M; KELLY C; RINALDI MG; PATTERSON JE
      EVALUATION OF PULSED-FIELD GEL-ELECTROPHORESIS AS A TYPING SYSTEM FORCANDIDA-RUGOSA - COMPARISON OF KARYOTYPE AND RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS

      Journal of clinical microbiology
    89. REX JH; PFALLER MA; LANCASTER M; ODDS FC; BOLMSTROM A; RINALDI MG
      QUALITY-CONTROL GUIDELINES FOR NATIONAL-COMMITTEE FOR CLINICAL LABORATORY STANDARDS-RECOMMENDED BROTH MACRODILUTION TESTING OF KETOCONAZOLEAND ITRACONAZOLE

      Journal of clinical microbiology
    90. KING D; CHEEVER LW; HOOD A; HORN TD; RINALDI MG; MERZ WG
      PRIMARY INVASIVE CUTANEOUS MICROSPORUM-CANIS INFECTIONS IN IMMUNOCOMPROMISED PATIENTS

      Journal of clinical microbiology
    91. PATTERSON TF; KIRKPATRICK WR; REVANKAR SG; MCATEE RK; FOTHERGILL AW; MCCARTHY DI; RINALDI MG
      COMPARATIVE-EVALUATION OF MACRODILUTION AND CHROMOGENIC AGAR SCREENING FOR DETERMINING FLUCONAZOLE SUSCEPTIBILITY OF CANDIDA-ALBICANS

      Journal of clinical microbiology
    92. MUNIPALLI B; RINALDI MG; GREENBERG SB
      COKEROMYCES RECURVATUS ISOLATED FROM PLEURAL AND PERITONEAL-FLUID - CASE-REPORT

      Journal of clinical microbiology
    93. WEITZMAN I; MCGOUGH DA; RINALDI MG; DELLALATTA P
      RHIZOPUS SCHIPPERAE, SP-NOV, A NEW AGENT OF ZYGOMYCOSIS

      Mycotaxon
    94. LARSEN RA; BAUER M; WEINER JM; DIAMOND DM; LEAL ME; DING JC; RINALDI MG; GRAYBILL JR
      EFFECT OF FLUCONAZOLE ON FUNGICIDAL ACTIVITY OF FLUCYTOSINE IN MURINECRYPTOCOCCAL MENINGITIS

      Antimicrobial agents and chemotherapy
    95. PATTERSON TF; PETERS J; LEVINE SM; ANZUETO A; BRYAN CL; SAKO EY; MILLER OL; CALHOON JH; RINALDI MG
      SYSTEMIC AVAILABILITY OF ITRACONAZOLE IN LUNG TRANSPLANTATION

      Antimicrobial agents and chemotherapy
    96. BARCHIESI F; NAJVAR LK; LUTHER MF; SCALISE G; RINALDI MG; GRAYBILL JR
      VARIATION IN FLUCONAZOLE EFFICACY FOR CANDIDA-ALBICANS STRAINS SEQUENTIALLY ISOLATED FROM ORAL CAVITIES OF PATIENTS WITH AIDS IN AN EXPERIMENTAL MURINE CANDIDIASIS MODEL

      Antimicrobial agents and chemotherapy
    97. GRAYBILL JR; BOCANEGRA R; FOTHERGILL A; RINALDI MG
      BLEOMYCIN THERAPY OF EXPERIMENTAL DISSEMINATED CANDIDIASIS IN MICE

      Antimicrobial agents and chemotherapy
    98. ANAISSIE EJ; PAETZNICK VL; ENSIGN LG; ESPINELINGROFF A; GALGIANI JN; HITCHCOCK CA; LAROCCO M; PATTERSON T; PFALLER MA; REX JH; RINALDI MG
      MICRODILUTION ANTIFUNGAL SUSCEPTIBILITY TESTING OF CANDIDA-ALBICANS AND CRYPTOCOCCUS-NEOFORMANS WITH AND WITHOUT AGITATION - AN 8-CENTER COLLABORATIVE STUDY

      Antimicrobial agents and chemotherapy
    99. REVANKAR SG; KIRKPATRICK WR; MCATEE RK; DIB OP; FOTHERGILL AW; REDDING SW; RINALDI MG; PATTERSON TF
      DETECTION AND SIGNIFICANCE OF FLUCONAZOLE RESISTANCE IN OROPHARYNGEALCANDIDIASIS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS

      The Journal of infectious diseases
    100. BRADLEY LL; REDDING SW; PFALLER MA; PROWS JJ; RINALDI MG; FOTHERGILL AW
      DNA SUBTYPE DIVERSITY OF OROPHARYNGEAL CANDIDIASIS IN AIDS

      Journal of dental research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 13/08/20 alle ore 02:44:10